Citicoline Improves Focus, Inhibition in WomenCiticoline Improves Focus, Inhibition in Women

SALT LAKE CITYHealthy, middle-aged women taking supplements of citicoline (as Cognizin® from Kyowa Hakko), a naturally occurring brain health nutrient, saw improved attentional focus and inhibition, according to a peer-reviewed study conducted by University of Utah scientists. The study was published in Food and Nutrition Sciences (20 June 2012).  
 
The double blind, placebo-controlled study was composed of 60 healthy women between 40 and 60 years of age. After 28 days of citicoline administration, the study participants taking 250 mg indicated improved performance on cognitive function tests, and those taking 500 mg showed improvement and made significantly fewer errors on the tests compared to those in the placebo group.

Our study findings indicate that citicoline supplementation was associated with improved attention focus and inhibition in a group of healthy female adult volunteers," according to the studys authors. Prior research has shown that citicoline administration improved attention in a variety of patient populations, including those with cognitive deficits associated with illness or injury, but this study included only healthy, middle-aged women."
 
The study participants were divided into three groups; those taking a 250-mg dose and a 500-mg dose of Cognizin, and those taking a placebo. Previous research has also been conducted showing Cognizin to have attention benefits.
 
 To our knowledge, this study is the first to examine the effects of low doses of citicoline on cognitive performance in healthy female adults," the authors said. Practical applications of this research include the possible use of citicoline supplementation to improve cognitive deficits associated with normal aging, stress, and psychiatric disorders."